Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiu-Chai Zheng"'
Autor:
Xiao-Chuan Duan, Shuang Zhang, Xuan Zhang, Yi-Fan Yin, Wei Ren, Zhan-Tao Li, Hui Li, Yan-Li Hao, Man Liu, Mei-Qi Xu, Ting Zhong, Zhuo-Yue Li, Xiu-Chai Zheng
Publikováno v:
International Journal of Nanomedicine
Xiu-Chai Zheng,1,2,* Wei Ren,1,2,* Shuang Zhang,1,2 Ting Zhong,1,2 Xiao-Chuan Duan,1,2 Yi-Fan Yin,1,2 Mei-Qi Xu,1,2 Yan-Li Hao,1,2 Zhan-Tao Li,1,2 Hui Li,1,2 Man Liu,1,2 Zhuo-Yue Li,1,2 Xuan Zhang1,2 1Beijing Key Laboratory of Molecular Pharmaceutics
Autor:
Shuang Zhang, Jing-Ru Wang, Yan-Li Hao, Zhan-Tao Li, Xiao-Chuan Duan, Xin Yao, Mei-Qi Xu, Xuan Zhang, Xiu-Chai Zheng, Zhen-Han Feng, Man Liu, Hui Li, Zhuo-Yue Li
Publikováno v:
International Journal of Nanomedicine
Xiao-Chuan Duan,1,2,* Xin Yao,1,2,* Shuang Zhang,1,2 Mei-Qi Xu,1,2 Yan-Li Hao,1,2 Zhan-Tao Li,1,2 Xiu-Chai Zheng,2 Man Liu,1,2 Zhuo-Yue Li,1,2 Hui Li,1 Jing-Ru Wang,1,2 Zhen-Han Feng,1 Xuan Zhang1,2 1Beijing Key Laboratory of Molecular Pharmaceutics
Autor:
Zhuo-Yue Li, Yan-Li Hao, Xiu-Chai Zheng, Shuang Zhang, Xuan Zhang, Jing-Ru Wang, Mei-Qi Xu, Man Liu, Xiao-Chuan Duan, Hui Li, Zhen-Han Feng, Zhan-Tao Li
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 295
Nucleus-targeting drug delivery systems (NTDDs) deliver chemotherapeutic agents to nuclei in order to improve the efficacy of anti-tumour therapy. Histone H1 (H1) plays a key role in establishing and maintaining higher order chromatin structures and
Autor:
Ting Zhong, Mei-Qi Xu, Zhan-Tao Li, Hui Li, Shuang Zhang, Yan-Li Hao, Xuan Zhang, Xiao-Chuan Duan, Xin Yao, Yang Guo, Xiu-Chai Zheng, Yi-Fan Yin
Publikováno v:
Bioconjugate chemistry. 29(2)
Small molecule modified anticancer drug conjugates (SMMDCs) can self-assemble into nanoparticles (NPs) as therapeutic NP platforms for cancer treatment. Here we demonstrate that the XlogP and Hansen solubility parameters of paclitaxel (PTX) SMMDCs is
Autor:
Shuang Zhang, Wen-Ding Song, Qiang Zhang, Yang Guo, Yi-Fan Yin, Xiao-Chuan Duan, Xuan Zhang, Xiu-Chai Zheng, Xin Yao, Ting Zhong, Mei-Qi Xu
Publikováno v:
AAPS PharmSciTech. 19(2)
Here, the mesoporous silica (Sylysia 350) was selected as mesoporous material, hydroxypropyl methylcellulose (HPMC) was selected as crystallization inhibitor, and febuxostat (FBT) was selected as model drug, respectively. The FBT-Sylysia-HPMC nanomat
Autor:
Xiao-Chuan Duan, Xin Yao, Shuang Zhang, Mei-Qi Xu, Yan-Li Hao, Zhan-Tao Li, Xiu-Chai Zheng, Man Liu, Zhuo-Yue Li, Hui Li, Jing-Ru Wang, Zhen-Han Feng, Xuan Zhang
Publikováno v:
International Journal of Nanomedicine; Jan2019, Vol. 14, p195-204, 10p, 1 Diagram, 3 Charts, 4 Graphs